These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6809444)

  • 1. Biological markers of melancholia and reclassification of depressive disorders.
    Greden JF
    Encephale; 1982; 8(2):193-202. PubMed ID: 6809444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Weissenburger JE; Fulton CL; Fairchild CJ; Roffwarg HP
    Biol Psychiatry; 1997 May; 41(9):915-28. PubMed ID: 9110097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet MAO activity, TRH test, and dexamethasone suppression test in depressed patients.
    Loosen PT; Marciniak R
    Pharmacopsychiatry; 1988 May; 21(3):131-5. PubMed ID: 3136464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychoneuroendocrinology of depression.
    Brown GM
    Psychiatr J Univ Ott; 1989 Jun; 14(2):344-8; discussion 349-51. PubMed ID: 2503840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The relation between results of thyrotropin-releasing hormone stimulation tests (TRH-ST), dexamethasone suppression test (DST) and urinary MHPG. SO4 excretion in depressive patients].
    Chen G
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Aug; 24(4):203-6, 251. PubMed ID: 1954790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine abnormalities in affective disorders.
    Extein I; Pottash AL; Gold MS
    Encephale; 1982; 8(2):203-11. PubMed ID: 6809445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
    Esel E; Kartalci S; Tutus A; Turan T; Sofuoglu S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):303-9. PubMed ID: 14751427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The correlation of dexamethasone suppression test and thyrotropin-releasing hormone test results in different subtypes of depression.
    D'Haenen H; Kaufman L; De Weert D; Cornet C; Raets I
    Acta Psychiatr Belg; 1984; 84(3):228-34. PubMed ID: 6435395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep EEG and dexamethasone suppression test findings in outpatients with unipolar major depressive disorders.
    Rush AJ; Giles DE; Roffwarg HP; Parker CR
    Biol Psychiatry; 1982 Mar; 17(3):327-41. PubMed ID: 7082700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological markers for endogenous depression in series and parallel.
    Feinberg M; Carroll BJ
    Biol Psychiatry; 1984 Jan; 19(1):3-11. PubMed ID: 6704459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine responses after thyrotrophin-releasing hormone stimulation and dexamethasone suppression tests in the major depressive syndrome.
    Aalbers C; Taljaard JJ; Gagiano CA
    S Afr Med J; 1986 Oct; 70(8):464-8. PubMed ID: 3095937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships among the TRH, REM latency, and dexamethasone suppression tests: preliminary findings.
    Rush AJ; Schlesser MA; Roffwarg HP; Giles DE; Orsulak PJ; Fairchild C
    J Clin Psychiatry; 1983 Aug; 44(8 Pt 2):23-9. PubMed ID: 6409892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, neuroendocrine, and sleep EEG diagnosis of "unusual" affective presentations: a practical review.
    Akiskal HS; Lemmi H
    Psychiatr Clin North Am; 1983 Mar; 6(1):69-83. PubMed ID: 6412218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of low-dose dexamethasone on sleep EEG patterns, plasma cortisol, and the TSH response to TRH in major depression.
    Poland RE; McCracken JT; Lutchmansingh P; Tondo L
    Pharmacopsychiatry; 1993 May; 26(3):79-83. PubMed ID: 8415898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EEG sleep, lithium transport, dexamethasone suppression, and monoamine oxidase activity in borderline personality disorder.
    Lahmeyer HW; Val E; Gaviria FM; Prasad RB; Pandey GN; Rodgers P; Weiler MA; Altman EG
    Psychiatry Res; 1988 Jul; 25(1):19-30. PubMed ID: 3217463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of serial neuroendocrine challenge studies in the management of depressive disorder.
    Targum SD
    Biol Psychiatry; 1983 Jan; 18(1):3-19. PubMed ID: 6403062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of depressive history on biological parameters in major depression].
    Van Wijnendaele R; Hubain P; Dramaix M; Mendlewicz J; Linkowski P
    Encephale; 2002; 28(1):51-8. PubMed ID: 11963343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biologic markers and prediction of response to treatment in depression].
    Uytdenhoef P; Linkowski P; Mendlewicz J
    Acta Psychiatr Belg; 1982; 82(3):229-42. PubMed ID: 6187184
    [No Abstract]   [Full Text] [Related]  

  • 19. Persistent neuroendocrine dysregulation in major depressive disorder: a marker for early relapse.
    Targum SD
    Biol Psychiatry; 1984 Mar; 19(3):305-18. PubMed ID: 6426529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Problems with diagnostic criteria for depression.
    Carroll BJ
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):14-8. PubMed ID: 6376481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.